TANDEM DIABETES CARE INC (TNDM) Form 8-K — May 15, 2026

$TNDMForm 8-KItems 5.02Filed May 15, 2026, 7:59 AM ET0001438133-26-000052Original filing

Tandem Diabetes Care announced the termination of Mark Novara, its Executive Vice President and Chief Commercial Officer, effective May 18, 2026. The departure was without cause, marking a significant shift in the company's senior commercial leadership. The company stated that its overall strategy and 2026 goals remain unchanged following the announcement.

Price after filing

1 day: 0.0%7 days: +11.4%30 days: +11.7%

Close on the filing date to close N calendar days later (from $14.15). Historical, not a forecast.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.